Autologous vessels are the gold standard for small-diameter (<6 mm) vascular bypass; however, many patients lack suitable autologous tissues due to diseases or prior vein harvest. As an alternative, synthetic vascular grafts made from bioinert synthetic materials such as polytetrafluoroethylene (PTFE) are currently used in the medical field. The high long-term failure rate of these materials in the replacement of small vessels is known to be associated with the lack of proper signalling events by PTFE to vascular cells causing adverse hemodynamic, inflammatory or coagulatory conditions. Therefore, constant and pressing is the demand for a more biocompatible conduit with structure and function similar to native vessels. For this reason, bioresorbable scaffold constructs which can provide not only proper mechanical support, but also precise molecular cues, are desired (1). In particular, proper degradation kinetics and molecule release profiles are needed to facilitate remodeling and integration process in vivo over the time for long-term patency (2).

This content is only available via PDF.
You do not currently have access to this content.